TrialMedical oncology (Northwood, London, England)2015

Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.

Mengzhou Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.